Targeting SOX2 Protein with Peptide Aptamers for Therapeutic Gains against Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) is a predominant cancer type in developing countries such as China, where ESCC accounts for approximately 90% of esophageal malignancies. Lacking effective and targeted therapy contributes to the poor 5-year survival rate. Recent studies showed that about 30...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther
Main Authors: Liu, Kuancan, Xie, Fuan, Zhao, Tingting, Zhang, Rui, Gao, Anding, Chen, Yunyun, Li, Haiyan, Zhang, Shihui, Xiao, Zhangwu, Li, Jieping, Hong, Xiaoqian, Shang, Lei, Huang, Weifeng, Wang, Junkai, El-Rifai, Wael, Zaika, Alexander, Chen, Xi, Que, Jianwen, Lan, Xiaopeng
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7054732/
https://ncbi.nlm.nih.gov/pubmed/31991109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2020.01.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados